Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
from Oppenheimer issued a price target of $8.00 for CNTB on 2026-07-09 11:57:01.The adjusted price target was set to $8.00.At the time of the announcement, CNTB was...
July 9, 2026 CNTB 22.30%
from Wells Fargo issued a price target of $15.00 for VALE on 2026-07-09 10:35:53.The adjusted price target was set to $15.00.At the time of the announcement, VALE...
July 9, 2026 VALE 0.96%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CNTB Connect Biopharma Holding | 2.72
22.30% | ||||||||||||||||||
| LGHL Lion Group Holding Ltd. | 0.36
15.69% | ||||||||||||||||||
| ASX ASE Technology Holding Co | 44.22
10.76% | ||||||||||||||||||
| IMOS ChipMOS TECHNOLOGIES Inc. | 75.37
10.72% | ||||||||||||||||||
| AKO-B Embotelladora Andina S.A. | 30.83
8.18% | ||||||||||||||||||
| FORTY Formula Systems (1985) Lt | 119.70
7.81% | ||||||||||||||||||
| HIMX Himax Technologies, Inc. | 15.99
7.32% | ||||||||||||||||||
| IQ iQIYI, Inc. | 1.13
7.14% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -0.45%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -1.55%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA -1.55%